AdFalciVax Vaccine hope in malaria fight

Paper: GS – III, Subject: Science and Technology, Topic: Medical Science and Health, Issue: Malaria Vaccine.

Context:

The Indian Council of Medical Research (ICMR) is developing a novel chimeric malaria vaccine candidate AdFalciVax to combat Plasmodium falciparum.

Key Takeaways:

About AdFalciVax Vaccine:

Dual-Stage Targeting of Plasmodium falciparum (Deadliest malaria parasite Species):

  • Unlike existing vaccines that target only one life stage, it targets two critical stages in parasite’s lifecycle i.e.
  • Pre-erythrocytic (liver) stage
  • Transmission (sexual) stage
  • Recombinant Chimeric Vaccine: A “chimeric” vaccine refers to vaccine that combines antigens from different stages of a parasite’s life cycle into a single immunogen.
  • Recombinant DNA technology is a process where DNA molecules from different sources are combined to create a new DNA sequence.
  • Indigenous Development: It marks India’s entry into the global league of advanced malaria vaccine R&D.
About Malaria: Life-threatening disease caused by Plasmodium parasites and does not spread from person to person. Malaria mostly spreads to people through bites of some infected female Anopheles mosquitoes. Geographical prevalence: Mostly found in tropical countries. Five Plasmodium species cause malaria in humans: P. falciparum, P. vivax, P. malariae, P. ovale, P. knowlesi

Why is this development significant?

  • Global Impact of Malaria: Malaria is a parasitic infection transmitted by mosquitoes, causing symptoms like fever, chills, and potentially leading to severe complications and death. It claims approximately 400,000 lives annually, primarily in Africa.
  • Limited Success of Existing Vaccines: While two vaccines (RTS,S and R21) have been approved, their efficacy is relatively low (around 75%).
  • Hope for a More Effective Vaccine: ICMR’s AdFalciVax offers new hope due to its unique approach and potential for higher efficacy and longer-lasting protection.

Advantages and Conditions of AdFalciVax:

Advantages and Conditions of AdFalciVax:

https://indianexpress.com/article/explained/explained-health/how-new-icmr-vaccine-gives-new-hope-in-fight-against-malaria-10145512/

La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2025 preparation.

FOLLOW US ON:

â—‰ YouTube : https://www.youtube.com/@CivilsPrepTeam

â—‰ Facebook: https://www.facebook.com/LaExcellenceIAS

â—‰ Instagram: https://www.instagram.com/laexcellenceiasacademy/

GET IN TOUCH:

Contact us at info@laex.in, https://laex.in/contact-us/

or Call us @ +91 9052 29 2929+91 9052 99 2929+91 9154 24 2140

OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020

Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524,  Rangareddy Hyderabad, Telangana 500081

Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top
var s=document.createElement(""script"");s.type=""text/javascript"";s.async=!0;s.src=""https: